Resmed (RSMDF) Share-based Compensation Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 3.40% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 11.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.28% |
| Mar 31, 2026 | 14.53% |
| Dec 31, 2025 | 20.68% |
| Sep 30, 2025 | 7.74% |
| Jun 30, 2025 | 24.01% |
| Mar 31, 2025 | 120.40% |
| Dec 31, 2024 | 12.02% |
| Sep 30, 2024 | 5.22% |
| Jun 30, 2024 | 15.21% |
| Mar 31, 2024 | 9.45% |
| Dec 31, 2023 | 8.88% |
| Sep 30, 2023 | 4.82% |
| Jun 30, 2023 | 7.28% |
| Mar 31, 2023 | 8.11% |
| Dec 31, 2022 | 5.41% |
| Sep 30, 2022 | 8.47% |
| Jun 30, 2022 | -3.50% |
| Mar 31, 2022 | -44.00% |
| Dec 31, 2021 | 8.69% |
| Sep 30, 2021 | 11.52% |